Innate and adaptive immune responses to herpes simplex virus

Viruses

Volumn 1, Issue 3, 2009, Pages 979-1002

  Chew, Tracy ^a   Taylor, Kathryne E ^a   Mossman, Karen L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adaptive immunity; Antiviral signaling; Herpes Simplex virus (HSV); Innate immunity; Natural Killer (NK) cells; Plasmacytoid Dendritic Cells (pDCs); Type I Interferon (IFN)

Indexed keywords

EID: 77954904912     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030979     Document Type: Review

References (184)

1. Ellermann-Eriksen, S.; Liberto, M.; Iannello, D.; Mogensen, S. X-linkage of the early in vitro alpha/beta interferon response of mouse peritoneal macrophages to herpes simplex virus type 2. J Gen Virol 1986, 67 (Pt 6), 1025-1033.
2. Gresser, I.; Tovey, M.; Maury, C.; Bandu, M. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med 1976, 144, 1316-1323.
3. Lopez, C. Genetics of natural resistance to herpesvirus infections in mice. Nature 1975, 258, 152-153.
4. Pedersen, E.; Haahr, S.; Mogensen, S. X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production. Infect Immun 1983, 42, 740-746.
5. Shupack, J.; Stiller, M.; Davis, I.; Kenny, C.; Jondreau, L. Topical alpha-interferon ointment with dimethyl sulfoxide in the treatment of recurrent genital herpes simplex. Dermatology 1992, 184, 40-44.
6. Vollstedt, S.; Arnold, S.; Schwerdel, C.; Franchini, M.; Alber, G.; Di Santo, J.; Ackermann, M.; Suter, M. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 2004, 78, 3846-3850.
7. Zawatzky, R.; Engler, H.; Kirchner, H. Experimental infection of inbred mice with herpes simplex virus. III. Comparison between newborn and adult C57BL/6 mice. J Gen Virol 1982, 60, 25-29.
8. Zawatzky, R.; Gresser, I.; DeMaeyer, E.; Kirchner, H. The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J Infect Dis 1982, 146, 405-410.
9. Zawatzky, R.; Kirchner, H.; DeMaeyer-Guignard, J.; DeMaeyer, E. An X-linked locus influences the amount of circulating interferon induced in the mouse by herpes simplex virus type 1. J Gen Virol 1982, 63, 325-332.
10. Biron, C.; Brossay, L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001, 13, 458-464.
11. Cerwenka, A.; Lanier, L. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001, 181, 158-169.
12. Cooper, M.; Fehniger, T.; Caligiuri, M. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22, 633-640.
13. Kurago, Z.; Lutz, C.; Smith, K.; Colonna, M. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLAB7 variants and target cells. J Immunol 1998, 160, 1573-1580.
14. Lund, J.; Sato, A.; Akira, S.; Medzhitov, R.; Iwasaki, A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198, 513-520.
15. Milligan, G. N.; Bernstein, D. I. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 1995, 206, 234-241.
16. Morrison, L. A.; Zhu, L.; Thebeau, L. G. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J Virol 2001, 75, 1195-1204.
17. Seppanen, M.; Meri, S.; Notkola, I.-L.; Seppala, I. J. T.; Hiltunen-Back, E.; Sarvas, H.; Lappalainen, M.; Valimaa, H.; Palikhe, A.; Valtonen, V. V.; Lokki, M.-L. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. J Infect Dis 2006, 194, 571-578.
18. Rouse, B. T.; Gierynska, M. Immunity to herpes simplex virus: a hypothesis. Herpes: the journal of the IHMF 2001, 8 Suppl 1, 2A-5A.
19. Dobbs, M. E.; Strasser, J. E.; Chu, C.-F.; Chalk, C.; Milligan, G. N. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin-or Fas-mediated cytolytic mechanisms. J Virol 2005, 79, 14546-14554.
20. Iijima, N.; Linehan, M. M.; Zamora, M.; Butkus, D.; Dunn, R.; Kehry, M. R.; Laufer, T. M.; Iwasaki, A. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J Exp Med 2008, 205, 3041-3052.
21. Milligan, G. N.; Bernstein, D. I. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 1997, 229, 259-268.
22. Milligan, G. N.; Dudley-McClain, K. L.; Young, C. G.; Chu, C.-F. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice. J Reprod Immunol 2004, 61, 115-127.
23. Johnson, A. J.; Chu, C.-F.; Milligan, G. N. Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J Virol 2008, 82, 9678-9688.
24. Ellermann-Eriksen, S.; Justesen, J.; Mogensen, S. Genetically determined difference in the antiviral action of alpha/beta interferon in cells from mice resistant or susceptible to herpes simplex virus type 2. J Gen Virol 1986, 67 (Pt 9), 1859-1866.
25. Stulting, R.; Kindle, J.; Nahmias, A. Patterns of herpes simplex keratitis in inbred mice. Invest Ophthalmol Vis Sci 1985, 26, 1360-1367.
26. Pepose, J.; Whittum-Hudson, J. An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice. Invest Ophthalmol Vis Sci 1987, 28, 1549-1552.
27. Abghari, S.; Stulting, R.; Nigida, S.; Downer, D.; Nahmias, A. Comparative replication of HSV-1 in BALB/c and C57BL/6 mouse embryo fibroblasts in vitro. Invest Ophthalmol Vis Sci 1986, 27, 909-914.
28. Kastrukoff, L.; Lau, A.; Kim, S. Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1. Ann Neurol 1987, 22, 52-59.
29. Vahlne, A.; Nilheden, E.; Svennerholm, B. Multiplicity activation of herpes simplex virus in mouse neuroblastoma (C1300) cells. Arch Virol 1981, 70, 345-356.
30. Thomas, E.; Lau, A.; Kim, S.; Osborne, D.; Kastrukoff, L. Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice. J Gen Virol 1991, 72 (Pt 9), 2051-2057.
31. Abghari, S.; Stulting, R.; Zhu, Z.; Schinazi, R.; Kaufman, H. Effect of genetically determined host factors on the efficacy of vidarabine, acyclovir and 5-trifluorothymidine in herpes simplex virus type 1 infection. Ophthalmic Res 1994, 26, 95-104.
32. Peterson, S.; Kurimasa, A.; Oshimura, M.; Dynan, W.; Bradbury, E.; Chen, D. Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc Natl Acad Sci U S A 1995, 92, 3171-3174.
33. Halford, W. P.; Balliet, J. W.; Gebhardt, B. M. Re-evaluating natural resistance to herpes simplex virus type 1. J Virol 2004, 78, 10086-10095.
34. Murphy, J.; Duerst, R.; Smith, T.; Morrison, L. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 2003, 77, 9337-9345.
35. Gill, N.; Deacon, P.; Lichty, B.; Mossman, K.; Ashkar, A. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J Virol 2006, 80, 9943-9950.
36. Svensson, A.; Bellner, L.; Magnusson, M.; Eriksson, K. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection. J Reprod Immunol 2007, 74, 114-123.
37. Leib, D.; Harrison, T.; Laslo, K.; Machalek, M.; Moorman, N.; Virgin, H. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med 1999, 189, 663-672.
38. Luker, G.; Prior, J.; Song, J.; Pica, C.; Leib, D. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol 2003, 77, 11082-11093.
39. Casrouge, A.; Zhang, S.; Eidenschenk, C.; Jouanguy, E.; Puel, A.; Yang, K.; Alcais, A.; Picard, C.; Mahfoufi, N.; Nicolas, N.; Lorenzo, L.; Plancoulaine, S.; Senechal, B.; Geissmann, F.; Tabeta, K.; Hoebe, K.; Du, X.; Miller, R.; Heron, B.; Mignot, C.; de Villemeur, T.; Lebon, P.; Dulac, O.; Rozenberg, F.; Beutler, B.; Tardieu, M.; Abel, L.; Casanova, J. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006, 314, 308-312.
40. Dupuis, S.; Jouanguy, E.; Al-Hajjar, S.; Fieschi, C.; Al-Mohsen, I.; Al-Jumaah, S.; Yang, K.; Chapgier, A.; Eidenschenk, C.; Eid, P.; Al Ghonaium, A.; Tufenkeji, H.; Frayha, H.; Al-Gazlan, S.; Al-Rayes, H.; Schreiber, R.; Gresser, I.; Casanova, J. Impaired response to interferonalpha/ beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003, 33, 388-391.
41. Zhang, S.; Jouanguy, E.; Ugolini, S.; Smahi, A.; Elain, G.; Romero, P.; Segal, D.; Sancho-Shimizu, V.; Lorenzo, L.; Puel, A.; Picard, C.; Chapgier, A.; Plancoulaine, S.; Titeux, M.; Cognet, C.; von Bernuth, H.; Ku, C.; Casrouge, A.; Zhang, X.; Barreiro, L.; Leonard, J.; Hamilton, C.; Lebon, P.; Heron, B.; Vallee, L.; Quintana-Murci, L.; Hovnanian, A.; Rozenberg, F.; Vivier, E.; Geissmann, F.; Tardieu, M.; Abel, L.; Casanova, J. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317, 1522-1527.
42. Alexopoulou, L.; Holt, A.; Medzhitov, R.; Flavell, R. Recognition of double-stranded RNA and activation of NF-[kappa]B by Toll-like receptor 3. Nature 2001, 413, 732-738.
43. Fernandes-Alnemri, T.; Yu, J.-W.; Datta, P.; Wu, J.; Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458, 509-513.
44. Hornung, V.; Ablasser, A.; Charrel-Dennis, M.; Bauernfeind, F.; Horvath, G.; Caffrey, D. R.; Latz, E.; Fitzgerald, K. A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458, 514-518.
45. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K. J.; Yamaguchi, O.; Otsu, K.; Tsujimura, T.; Koh, C.-S.; Reis e Sousa, C.; Matsuura, Y.; Fujita, T.; Akira, S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441, 101-105.
46. Limmon, G. V.; Arredouani, M.; McCann, K. L.; Corn Minor, R. A.; Kobzik, L.; Imani, F. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J 2008, 22, 159-167.
47. Muruve, D. A.; Pétrilli, V.; Zaiss, A. K.; White, L. R.; Clark, S. A.; Ross, P. J.; Parks, R. J.; Tschopp, J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452, 103-107.
48. Aravalli, R. N.; Hu, S.; Rowen, T. N.; Palmquist, J. M.; Lokensgard, J. R. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 2005, 175, 4189-4193.
49. Kurt-Jones, E. A.; Chan, M.; Zhou, S.; Wang, J.; Reed, G.; Bronson, R.; Arnold, M. M.; Knipe, D. M.; Finberg, R. W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101, 1315-1320.
50. Hemmi, H.; Takeuchi, O.; Kawai, T.; Kaisho, T.; Sato, S.; Sanjo, H.; Matsumoto, M.; Hoshino, K.; Wagner, H.; Takeda, K.; Akira, S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408, 740-745.
51. Hausmann, S.; Marq, J.-B.; Tapparel, C.; Kolakofsky, D.; Garcin, D. RIG-I and dsRNA-induced IFNbeta activation. PLoS ONE 2008, 3, e3965.
52. Kato, H.; Takeuchi, O.; Mikamo-Satoh, E.; Hirai, R.; Kawai, T.; Matsushita, K.; Hiiragi, A.; Dermody, T. S.; Fujita, T.; Akira, S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205, 1601-1610.
53. Takaoka, A.; Wang, Z.; Choi, M. K.; Yanai, H.; Negishi, H.; Ban, T.; Lu, Y.; Miyagishi, M.; Kodama, T.; Honda, K.; Ohba, Y.; Taniguchi, T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448, 501-505.
54. Chiu, Y.-H.; Macmillan, J. B.; Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138, 576-591.
55. Wang, Z.; Choi, M. K.; Ban, T.; Yanai, H.; Negishi, H.; Lu, Y.; Tamura, T.; Takaoka, A.; Nishikura, K.; Taniguchi, T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 2008, 105, 5477-5482.
56. Rasmussen, S. B.; Jensen, S. B.; Nielsen, C.; Quartin, E.; Kato, H.; Chen, Z. J.; Silverman, R. H.; Akira, S.; Paludan, S. R. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J Gen Virol 2009, 90, 74-78.
57. Rasmussen, S. B.; Sørensen, L. N.; Malmgaard, L.; Ank, N.; Baines, J. D.; Chen, Z. J.; Paludan, S. R. Type I interferon production during herpes simplex virus infection is controlled by celltype-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol 2007, 81, 13315-13324.
58. Cheng, G.; Zhong, J.; Chung, J.; Chisari, F. V. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci USA 2007, 104, 9035-9040.
59. Krug, A.; Luker, G. D.; Barchet, W.; Leib, D. A.; Akira, S.; Colonna, M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103, 1433-1437.
60. Lund, J.; Linehan, M.; Iijima, N.; Iwasaki, A. Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 2006, 177, 7510-7514.
61. Mansur, D.; Kroon, E.; Nogueira, M.; Arantes, R.; Rodrigues, S.; Akira, S.; Gazzinelli, R.; Campos, M. Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol 2005, 166, 1419-1426.
62. Wuest, T.; Austin, B.; Uematsu, S.; Thapa, M.; Akira, S.; Carr, D. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J Neuroimmunol 2006, 179, 46-52.
63. Ashkar, A.; Rosenthal, K. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 2003, 77, 10168-10171.
64. Ashkar, A.; Yao, X.; Gill, N.; Sajic, D.; Patrick, A.; Rosenthal, K. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 2004, 190, 1841-1849.
65. Harandi, A.; Eriksson, K.; Holmgren, J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J Virol 2003, 77, 953-962.
66. Herbst-Kralovetz, M.; Pyles, R. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol 2006, 80, 9988-9997.
67. Pyles, R.; Higgins, D.; Chalk, C.; Zalar, A.; Eiden, J.; Brown, C.; Van Nest, G.; Stanberry, L. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J Virol 2002, 76, 11387-11396.
68. Sajic, D.; Ashkar, A.; Patrick, A.; McCluskie, M.; Davis, H.; Levine, K.; Holl, R.; Rosenthal, K. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge. J Med Virol 2003, 71, 561-568.
69. Boivin, N.; Sergerie, Y.; Rivest, S.; Boivin, G. Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis. J Infect Dis 2008, 198, 664-672.
70. Boyle, K.; Pietropaolo, R.; Compton, T. Engagement of the Cellular Receptor for Glycoprotein B of Human Cytomegalovirus Activates the Interferon-Responsive Pathway. Mol. Cell. Biol. 1999, 19, 3607-3613.
71. Collins, S.; Noyce, R.; Mossman, K. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004, 78, 1706-1717.
72. Netterwald, J.; Jones, T.; Britt, W.; Yang, S.-J.; McCrone, I.; Zhu, H. Postattachment Events Associated with Viral Entry Are Necessary for Induction of Interferon-Stimulated Genes by Human Cytomegalovirus. J. Virol. 2004, 78, 6688-6691.
73. Noyce, R. S.; Collins, S. E.; Mossman, K. L. Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 2009, 83, 4013-4022.
74. Paladino, P.; Cummings, D.; Noyce, R.; Mossman, K. The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 2006, 177, 8008-8016.
75. Prescott, J.; Ye, C.; Sen, G.; Hjelle, B. Induction of Innate Immune Response Genes by Sin Nombre Hantavirus Does Not Require Viral Replication. J. Virol. 2005, 79, 15007-15015.
76. Preston, C.; Harman, A.; Nicholl, M. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 2001, 75, 8909-8916.
77. Duncan, J. A.; Bergstralh, D. T.; Wang, Y.; Willingham, S. B.; Ye, Z.; Zimmermann, A. G.; Ting, J. P.-Y. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA 2007, 104, 8041-8046.
78. Mariathasan, S.; Weiss, D. S.; Newton, K.; McBride, J.; O'Rourke, K.; Roose-Girma, M.; Lee, W. P.; Weinrauch, Y.; Monack, D. M.; Dixit, V. M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440, 228-232.
79. Pétrilli, V.; Papin, S.; Dostert, C.; Mayor, A.; Martinon, F.; Tschopp, J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007, 14, 1583-1589.
80. Fitzgerald, K.; McWhirter, S.; Faia, K.; Rowe, D.; Latz, E.; Golenbock, D.; Coyle, A.; Liao, S.; Maniatis, T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003, 4, 491-496.
81. Sharma, S.; tenOever, B.; Grandvaux, N.; Zhou, G.-P.; Lin, R.; Hiscott, J. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway. Science 2003, 300, 1148-1151.
82. Zhong, B.; Yang, Y.; Li, S.; Wang, Y.-Y.; Li, Y.; Diao, F.; Lei, C.; He, X.; Zhang, L.; Tien, P.; Shu, H.-B. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008, 29, 538-550.
83. McWhirter, S. M.; Fitzgerald, K. A.; Rosains, J.; Rowe, D. C.; Golenbock, D. T.; Maniatis, T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci USA 2004, 101, 233-238.
84. Grandvaux, N.; Servant, M.; tenOever, B.; Sen, G.; Balachandran, S.; Barber, G.; Lin, R.; Hiscott, J. Transcriptional Profiling of Interferon Regulatory Factor 3 Target Genes: Direct Involvement in the Regulation of Interferon-Stimulated Genes. J. Virol. 2002, 76, 5532-5539.
85. Kumar, K.; McBride, K.; Weaver, B.; Dingwall, C.; Reich, N. Regulated Nuclear-Cytoplasmic Localization of Interferon Regulatory Factor 3, a Subunit of Double-Stranded RNA-Activated Factor 1. Mol. Cell. Biol. 2000, 20, 4159-4168.
86. Lin, R.; Heylbroeck, C.; Pitha, P.; Hiscott, J. Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation. Mol. Cell. Biol. 1998, 18, 2986-2996.
87. Qin, B.; Liu, C.; Srinath, H.; Lam, S.; Correia, J.; Derynck, R.; Lin, K. Crystal Structure of IRF-3 in Complex with CBP. Structure 2005, 13, 1269-1277.
88. Qin, B. Y.; Liu, C.; Lam, S. S.; Srinath, H.; Delston, R.; Correia, J. J.; Derynck, R.; Lin, K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol 2003, 10, 913-921.
89. Takahasi, K.; Suzuki, N. N.; Horiuchi, M.; Mori, M.; Suhara, W.; Okabe, Y.; Fukuhara, Y.; Terasawa, H.; Akira, S.; Fujita, T.; Inagaki, F. X-ray crystal structure of IRF-3 and its functional implications. Nat Struct Biol 2003, 10, 922-927.
90. Lin, R.; Noyce, R.; Collins, S.; Everett, R.; Mossman, K. The herpes simplex virus ICP0 RING finger domain inhibits IRF3-and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004, 78, 1675-1684.
91. Melroe, G.; DeLuca, N.; Knipe, D. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol 2004, 78, 8411-8420.
92. Melroe, G.; Silva, L.; Schaffer, P.; Knipe, D. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology 2007, 360, 305-321.
93. Honda, K.; Yanai, H.; Negishi, H.; Asagiri, M.; Sato, M.; Mizutani, T.; Shimada, N.; Ohba, Y.; Takaoka, A.; Yoshida, N.; Taniguchi, T. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 2005, 434, 772-777.
94. D'Cunha, J.; Knight, E.; Haas, A.; Truitt, R.; Borden, E. Immunoregulatory properties of ISG15, an interferon-induced cytokine. PNAS 1996, 93, 211-215.
95. Guo, J.; Peters, K.; Sen, G. Induction of the Human Protein P56 by Interferon, Double-Stranded RNA, or Virus Infection. Virology 2000, 267, 209-219.
96. Hui, D.; Bhasker, C.; Merrick, W.; Sen, G. Viral Stress-inducible Protein p56 Inhibits Translation by Blocking the Interaction of eIF3 with the Ternary Complex eIF2{middle dot}GTP{middle dot}Met-tRNAi. J. Biol. Chem. 2003, 278, 39477-39482.
97. Marques, J.; Rebouillat, D.; Ramana, C.; Murakami, J.; Hill, J.; Gudkov, A.; Silverman, R.; Stark, G.; Williams, B. Down-Regulation of p53 by Double-Stranded RNA Modulates the Antiviral Response. J. Virol. 2005, 79, 11105-11114.
98. Zhou, A.; Hassel, B.; Silverman, R. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell 1993, 72, 753-765.
99. Paladino, P.; Mossman, K. L. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res 2009, 29, 599-607.
100. Lavau, C.; Marchio, A.; Fagioli, M.; Jansen, J.; Falini, B.; Lebon, P.; Grosveld, F.; Pandolfi, P. P.; Pelicci, P. G.; Dejean, A. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 1995, 11, 871-876.
101. Wang, Z. G.; Ruggero, D.; Ronchetti, S.; Zhong, S.; Gaboli, M.; Rivi, R.; Pandolfi, P. P. PML is essential for multiple apoptotic pathways. Nat Genet 1998, 20, 266-272.
102. Zheng, P.; Guo, Y.; Niu, Q.; Levy, D. E.; Dyck, J. A.; Lu, S.; Sheiman, L. A.; Liu, Y. Protooncogene PML controls genes devoted to MHC class I antigen presentation. Nature 1998, 396, 373-376.
103. Everett, R. D.; Maul, G. G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 1994, 13, 5062-5069.
104. Maul, G. G.; Everett, R. D. The nuclear location of PML, a cellular member of the C3HC4 zincbinding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 1994, 75 (Pt 6), 1223-1233.
105. Farrell, P. J.; Sen, G. C.; Dubois, M. F.; Ratner, L.; Slattery, E.; Lengyel, P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci USA 1978, 75, 5893-5897.
106. Al-Khatib, K.; Williams, B.; Silverman, R.; Halford, W.; Carr, D. Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. J Immunol 2004, 172, 5638-5647.
107. Carr, D.; Tomanek, L.; Silverman, R.; Campbell, I.; Williams, B. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. J Virol 2005, 79, 9341-9345.
108. He, B.; Gross, M.; Roizman, B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1997, 94, 843-848.
109. Poppers, J.; Mulvey, M.; Khoo, D.; Mohr, I. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol 2000, 74, 11215-11221.
110. Duerst, R. J.; Morrison, L. A. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 2004, 322, 158-167.
111. Karlhofer, F.; Ribaudo, R.; Yokoyama, W. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992, 358, 66-70.
112. Wagtmann, N.; Biassoni, R.; Cantoni, C.; Verdiani, S.; Malnati, M.; Vitale, M.; Bottino, C.; Moretta, L.; Moretta, A.; Long, E. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 1995, 2, 439-449.
113. Mocikat, R.; Braumuller, H.; Gumy, A.; Egeter, O.; Ziegler, H.; Reusch, U.; Bubeck, A.; Louis, J.; Mailhammer, R.; Riethmuller, G.; Koszinowski, U.; Rocken, M. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003, 19, 561-569.
114. York, I.; Roop, C.; Andrews, D.; Riddell, S.; Graham, F.; Johnson, D. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 1994, 77, 525-535.
115. Rola-Pleszczynski, M. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells. Kinetics in normal donors and patients with recurrent herpes labialis. J Clin Lab Immunol 1981, 6, 39-43.
116. Bishop, G.; Glorioso, J.; Schwartz, S. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med 1983, 157, 1544-1561.
117. Fitzgerald, P.; Mendelsohn, M.; Lopez, C. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. J Immunol 1985, 134, 2666-2672.
118. Smith, H.; Heusel, J.; Mehta, I.; Kim, S.; Dorner, B.; Naidenko, O.; Iizuka, K.; Furukawa, H.; Beckman, D.; Pingel, J.; Scalzo, A.; Fremont, D.; Yokoyama, W. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 2002, 99, 8826-8831.
119. Ghiasi, H.; Cai, S.; Perng, G.; Nesburn, A.; Wechsler, S. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res 2000, 45, 33-45.
120. Habu, S.; Akamatsu, K.; Tamaoki, N.; Okumura, K. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J Immunol 1984, 133, 2743-2747.
121. Nandakumar, S.; Woolard, S.; Yuan, D.; Rouse, B.; Kumaraguru, U. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. J Virol 2008, 82, 10820-10831.
122. Pereira, R.; Scalzo, A.; Simmons, A. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J Immunol 2001, 166, 5869-5873.
123. Staats, H.; Oakes, J.; Lausch, R. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. J Virol 1991, 65, 6008-6014.
124. Tanigawa, M.; Bigger, J.; Kanter, M.; Atherton, S. Natural killer cells prevent direct anterior-toposterior spread of herpes simplex virus type 1 in the eye. Invest Ophthalmol Vis Sci 2000, 41, 132-137.
125. Thapa, M.; Kuziel, W.; Carr, D. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 2007, 81, 3704-3713.
126. Bukowski, J.; Welsh, R. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol 1986, 136, 3481-3485.
127. Chmielarczyk, W.; Engler, H.; Ernst, R.; Opitz, U.; Kirchner, H. Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus. J Gen Virol 1985, 66 (Pt 5), 1087-1094.
128. Kassim, S.; Rajasagi, N.; Ritz, B.; Pruett, S.; Gardner, E.; Chervenak, R.; Jennings, S. Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1. J Virol 2009, 83, 3175-3186.
129. Mercurio, A.; Schwarting, G.; Robbins, P. Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp Med 1984, 160, 1114-1125.
130. Schuler, G. The dendritic, Thy-1-positive cell of murine epidermis: a new epidermal cell type of bone marrow origin. J Invest Dermatol 1984, 83, 81-82.
131. Suttles, J.; Schwarting, G.; Stout, R. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J Immunol 1986, 136, 1586-1591.
132. Wiltrout, R.; Santoni, A.; Peterson, E.; Knott, D.; Overton, W.; Herberman, R.; Holden, H. Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukoc Biol 1985, 37, 597-614.
133. Halford, W. P.; Maender, J. L.; Gebhardt, B. M. Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1. Virol J 2005, 2, 56.
134. Slifka, M.; Pagarigan, R.; Whitton, J. NK markers are expressed on a high percentage of virusspecific CD8+ and CD4+ T cells. J Immunol 2000, 164, 2009-2015.
135. Rager-Zisman, B.; Quan, P.; Rosner, M.; Moller, J.; Bloom, B. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J Immunol 1987, 138, 884-888.
136. Adler, H.; Beland, J.; Del-Pan, N.; Kobzik, L.; Sobel, R.; Rimm, I. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J Neuroimmunol 1999, 93, 208-213.
137. Williams, N.; Klem, J.; Puzanov, I.; Sivakumar, P.; Schatzle, J.; Bennett, M.; Kumar, V. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol Rev 1998, 165, 47-61.
138. Gill, N.; Rosenthal, K.; Ashkar, A. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol 2005, 79, 4470-4478.
139. Grubor-Bauk, B.; Simmons, A.; Mayrhofer, G.; Speck, P. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol 2003, 170, 1430-1434.
140. Brandt, C.; Salkowski, C. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest Ophthalmol Vis Sci 1992, 33, 113-120.
141. Gill, N.; Ashkar, A. Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2. J Virol 2009, 83, 918-926.
142. Tomazin, R.; van Schoot, N.; Goldsmith, K.; Jugovic, P.; Sempe, P.; Fruh, K.; Johnson, D. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 1998, 72, 2560-2563.
143. Ching, C.; Lopez, C. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun 1979, 26, 49-56.
144. Biron, C.; Byron, K.; Sullivan, J. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989, 320, 1731-1735.
145. Dalloul, A.; Oksenhendler, E.; Chosidow, O.; Ribaud, P.; Carcelain, G.; Louvet, S.; Massip, P.; Lebon, P.; Autran, B. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J Clin Virol 2004, 30, 329-336.
146. McKenna, K.; Beignon, A.; Bhardwaj, N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 2005, 79, 17-27.
147. Siegal, F.; Kadowaki, N.; Shodell, M.; Fitzgerald-Bocarsly, P.; Shah, K.; Ho, S.; Antonenko, S.; Liu, Y. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284, 1835-1837.
148. Hochrein, H.; Schlatter, B.; O'Keeffe, M.; Wagner, C.; Schmitz, F.; Schiemann, M.; Bauer, S.; Suter, M.; Wagner, H. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways. Proc Natl Acad Sci U S A 2004, 101, 11416-11421.
149. Wollenberg, A.; Wagner, M.; Gunther, S.; Towarowski, A.; Tuma, E.; Moderer, M.; Rothenfusser, S.; Wetzel, S.; Endres, S.; Hartmann, G. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 2002, 119, 1096-1102.
150. Kittan, N.; Bergua, A.; Haupt, S.; Donhauser, N.; Schuster, P.; Korn, K.; Harrer, T.; Schmidt, B. Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virusassociated acute retinal necrosis. J Immunol 2007, 179, 4219-4230.
151. Donaghy, H.; Bosnjak, L.; Harman, A.; Marsden, V.; Tyring, S.; Meng, T.; Cunningham, A. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol 2009, 83, 1952-1961.
152. Brown, Z. A.; Selke, S.; Zeh, J.; Kopelman, J.; Maslow, A.; Ashley, R. L.; Watts, D. H.; Berry, S.; Herd, M.; Corey, L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997, 337, 509-515.
153. Kuklin, N. A.; Daheshia, M.; Chun, S.; Rouse, B. T. Role of mucosal immunity in herpes simplex virus infection. J Immunol 1998, 160, 5998-6003.
154. Kohl, S.; Loo, L. S. The relative role of transplacental and milk immune transfer in protection against lethal neonatal herpes simplex virus infection in mice. J Infect Dis 1984, 149, 38-42.
155. Sherwood, J. K.; Zeitlin, L.; Whaley, K. J.; Cone, R. A.; Saltzman, M. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Nat Biotechnol 1996, 14, 468-471.
156. Zeitlin, L.; Whaley, K. J.; Sanna, P. P.; Moench, T. R.; Bastidas, R.; De Logu, A.; Williamson, R. A.; Burton, D. R.; Cone, R. A. Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2. Virology 1996, 225, 213-215.
157. Chu, C.-F.; Meador, M. G.; Young, C. G.; Strasser, J. E.; Bourne, N.; Milligan, G. N. Antibodymediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and-independent mechanisms. J Reprod Immunol 2008, 78, 58-67.
158. Milligan, G. N.; Meador, M. G.; Chu, C.-F.; Young, C. G.; Martin, T. L.; Bourne, N. Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2. J Virol 2005, 79, 11537-11540.
159. Para, M. F.; Baucke, R. B.; Spear, P. G. Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. J Virol 1980, 34, 512-520.
160. Baucke, R. B.; Spear, P. G. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol 1979, 32, 779-789.
161. Mitchell, B. M.; Stevens, J. G. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response. J Immunol 1996, 156, 246-255.
162. Deshpande, S. P.; Zheng, M.; Daheshia, M.; Rouse, B. T. Pathogenesis of herpes simplex virusinduced ocular immunoinflammatory lesions in B-cell-deficient mice. J Virol 2000, 74, 3517-3524.
163. Dudley, K. L.; Bourne, N.; Milligan, G. N. Immune protection against HSV-2 in B-cell-deficient mice. Virology 2000, 270, 454-463.
164. Mueller, S. N.; Jones, C. M.; Smith, C. M.; Heath, W. R.; Carbone, F. R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J Exp Med 2002, 195, 651-656.
165. Sheridan, B. S.; Cherpes, T. L.; Urban, J.; Kalinski, P.; Hendricks, R. L. Reevaluating the CD8 Tcell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. J Virol 2009, 83, 2237-2245.
166. Hosken, N.; McGowan, P.; Meier, A.; Koelle, D. M.; Sleath, P.; Wagener, F.; Elliott, M.; Grabstein, K.; Posavad, C.; Corey, L. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J Virol 2006, 80, 5509-5515.
167. Cantin, E.; Tanamachi, B.; Openshaw, H.; Mann, J.; Clarke, K. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFNgamma ligand null-mutant mice. J Virol 1999, 73, 5196-5200.
168. Wakim, L. M.; Jones, C. M.; Gebhardt, T.; Preston, C. M.; Carbone, F. R. CD8(+) T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection. Immunol Cell Biol 2008, 86, 666-675.
169. Cantin, E.; Hinton, D.; Chen, J.; Openshaw, H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 1995, 69, 4898-4905.
170. Posavad, C. M.; Huang, M. L.; Barcy, S.; Koelle, D. M.; Corey, L. Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes. J Immunol 2000, 165, 1146-1152.
171. Cantin, E.; Tanamachi, B.; Openshaw, H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol 1999, 73, 3418-3423.
172. Milligan, G. N.; Bernstein, D. I.; Bourne, N. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol 1998, 160, 6093-6100.
173. Balish, M.; Abrams, M.; Pumfery, A.; Brandt, C. Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and-gamma. J Infect Dis 1992, 166, 1401-1403.
174. Chen, S.; Oakes, J.; Lausch, R. Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Antiviral Res 1993, 22, 15-29.
175. Czarniecki, C.; Fennie, C.; Powers, D.; Estell, D. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol 1984, 49, 490-496.
176. Neumann-Haefelin, D.; Sundmacher, R.; Frey, H.; Merk, W. Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2. Med Microbiol Immunol 1985, 174, 81-86.
177. Zerial, A.; Hovanessian, A.; Stefanos, S.; Huygen, K.; Werner, G.; Falcoff, E. Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons. Antiviral Res 1982, 2, 227-239.
178. Sainz, B.; Halford, W. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol 2002, 76, 11541-11550.
179. Chee, A.; Lopez, P.; Pandolfi, P.; Roizman, B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 2003, 77, 7101-7105.
180. Pierce, A.; DeSalvo, J.; Foster, T.; Kosinski, A.; Weller, S.; Halford, W. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virusinfected cells. J Gen Virol 2005, 86, 2421-2432.
181. Pasieka, T.; Cilloniz, C.; Lu, B.; Teal, T.; Proll, S.; Katze, M.; Leib, D. Host responses to wildtype and attenuated herpes simplex virus infection in the absence of Stat1. J Virol 2009, 83, 2075-2087.
182. Le Bon, A.; Durand, V.; Kamphuis, E.; Thompson, C.; Bulfone-Paus, S.; Rossmann, C.; Kalinke, U.; Tough, D. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 2006, 176, 4682-4689.
183. Le Bon, A.; Etchart, N.; Rossmann, C.; Ashton, M.; Hou, S.; Gewert, D.; Borrow, P.; Tough, D. F. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003, 4, 1009-1015.
184. Trilling, M.; Le, V. T. K.; Zimmermann, A.; Ludwig, H.; Pfeffer, K.; Sutter, G.; Smith, G. L.; Hengel, H. Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol 2009, 83, 3684-3695.